Medigrowth

Medigrowth Australia is a fully licensed medicinal cannabis biotech company committed to producing pure, safe, and trusted Australian-made cannabinoid medicines. Operating since 2017, Medigrowth focuses on alleviating symptoms of various illnesses that significantly impact quality of life. The company distributes pharmaceutical-grade medicinal cannabis oils and locally grown dried cannabis flowers, adhering to Australian Good Manufacturing Practice (AU GMP) standards. Medigrowth serves a diverse clientele including patients, doctors, pharmacists, and research institutions, primarily within the Australian market.

The business model revolves around a B2B and B2C approach, where Medigrowth partners with healthcare providers and research organizations to advance clinical trials and real-world data initiatives in plant-based therapies. Revenue is generated through the sale of medicinal cannabis products and partnerships in research and clinical trials.

Medigrowth's mission is to provide exceptional quality medicinal cannabis to as many Australians as possible, aiming to improve patient health, wellbeing, and quality of life. The company is also dedicated to educating health practitioners about the benefits and functions of medicinal cannabis.

Keywords: medicinal cannabis, biotech, pharmaceutical-grade, AU GMP, cannabinoid medicine, B2B, clinical trials, Australian-made, patient health, plant-based therapies.